Karachi: Citi Pharma Ltd. has disclosed significant transactions regarding the transfer of its shares by a relevant person, Nadeem Amjad, under the guidelines of PSX Regulation 5.6.4. The transactions, all classified as "Gift Out," indicate a substantial movement of shares without monetary exchange.

The transactions were detailed in a series of transfers through the Central Depository Company (CDC) spanning from April 15 to May 8, 2025. On April 15, Nadeem Amjad transferred a total of 2,636,536 shares in three separate transactions, with individual transfers of 1,318,268, 659,134, and 329,567 shares respectively. An additional 329,567 shares were also transferred on the same day.

A significant transaction occurred on April 24, where 22.85 million shares were transferred. This particular movement stands out as the largest in the series of transactions.

Further transfers occurred on May 8, involving two separate transfers of 2.7 million shares each. These transactions collectively bring the total number of shares transferred by Nadeem Amjad to 30.89 million.

According to information available from the Pakistan Stock Exchange (PSX), these transactions reflect a notable exercise of share transfer rights under the stipulated stock market regulations. The nature of these transfers, being classified as "Gift Out," suggests a strategic reallocation of shares within the purview of the designated market category.

The disclosure of these transactions conforms to the transparency and regulatory requirements set forth by the PSX, providing crucial insights into the internal shareholding adjustments within Citi Pharma Ltd.